The global cryoglobulinemia treatment market is poised for significant growth, with an expected market value of US$ 496 ...

While the proven Zacks Rank places an emphasis on earnings estimates and estimate revisions to find strong stocks, we also know that investors tend to develop their own individual strategies. With ...

Barclays analyst Balaji Prasad maintained a Buy rating on Teva Pharmaceutical (TEVA – Research Report) today and set a price target of ...

We came across a bullish thesis on Teva Pharmaceutical Industries Limited (TEVA) on Kontra Investment Xchange’s Substack by ...

Teva (TEVA) and Alvotech (ALVO) said the FDA has expanded labeling for its biosimilar of Stelara to include the treatment of ...

Alvotech (ALVO) and Teva Pharmaceuticals, a U.S. affiliate of Teva Pharmaceutical Industries Ltd. (TEVA), announced the FDA has ...

The UK car industry has warned its efforts to support the transition to electric vehicles cannot be sustained indefinitely as it faces the prospect of fines for missing climate-linked sales targets.

On October 8, 2024, Teva Pharmaceutical Industries Ltd. announced that the United States Food and Drug Administration (FDA) has accepted, and ...

Teva Pharmaceuticals, the largest generic drug manufacturer in the United States, has agreed to pay $450 million to resolve allegations of ...

Teva Pharmaceutical Industries trades -15.56% away from its average analyst target price of $21.14 per share. The 7 analysts ...

Teva Pharmaceuticals Industries Ltd (NYSE:TEVA) has agreed to a $450 million settlement with the U.S. government to resolve ...

Teva Pharmaceuticals agreed to pay $25 million to settle False Claims Act violations related to drug price-fixing.